483 Novartis Pharma Stein AG Jun 2012

483 Novartis Pharma Stein AG Jun 2012

Jeffrey Meng FDA, Kim Thomas Cruse FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharma Stein AG - Stein AG, Switzerland facility and issued 5 inspectional observations (via FDA 483) on 22 Jun 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 22 Jun 2012
  • Location: Stein AG, Switzerland
  • FEI: 3002653483
Add To Cart